CUAMC
PRQR icon

China Universal Asset Management Company’s ProQR Therapeutics PRQR Stock Holding History

China Universal Asset Management Company’s Portfolio PRQR Stock Details PRQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$32.4K Buy
+20,000
New +$32.8K ﹤0.01% 478
2022
Q4 		– Sell
-701
Closed -$1K – 444
2022
Q3 		$1K Buy
+701
New +$563 ﹤0.01% 410

Other funds holding PRQR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PFM
Privium Fund Management Amsterdam, Netherlands $480M AUM 77.45% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

China Universal Asset Management Company's PRQR Position: Q1 2026 in Review

China Universal Asset Management Company opened a new position in ProQR Therapeutics (PRQR) in Q1 2026: 20,000 shares worth $32.4K. The stake represents ﹤0.01% of the portfolio and ranks #478 among its holdings. This is a return to the name: China Universal Asset Management Company previously reported a position in PRQR as recently as Q3 2022.

China Universal Asset Management Company first reported a position in PRQR in Q3 2022 and has held it in 2 quarters since. 69 funds tracked by Wall St. Rank hold PRQR as of Q1 2026.

  • China Universal Asset Management Company held 20,000 shares of ProQR Therapeutics worth $32.4K as of Q1 2026.
  • ProQR Therapeutics was a new China Universal Asset Management Company position in Q1 2026.
  • ProQR Therapeutics made up ﹤0.01% of China Universal Asset Management Company's portfolio in Q1 2026, its #478 holding.
  • China Universal Asset Management Company first reported a position in ProQR Therapeutics in Q3 2022 and has held it in 2 quarters since.
  • 69 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q1 2026.

Based on China Universal Asset Management Company's 13F filing for Q1 2026, filed 28 Apr 2026.